Overview

A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the Body

Status:
NOT_YET_RECRUITING
Trial end date:
2025-12-22
Target enrollment:
Participant gender:
Summary
The objective of this trial is to assess the effect of BI 3000202 on the pharmacokinetics of rosuvastatin and digoxin given as a cocktail.
Phase:
PHASE1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Digoxin
Rosuvastatin Calcium